Alto Neuroscience (NYSE:ANRO) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.65) by 4.62 percent.
- Headlines
- Alto Neuroscience Q3 2024 GAAP EPS $(0.62) Beats $(0.65) Estimate
Alto Neuroscience Q3 2024 GAAP EPS $(0.62) Beats $(0.65) Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
23:05
Boeing and the USA Department of Justice will gain more negotiation time regarding the final plea agreements for multiple crash incidents.
BA+0.87%
23:03
Smithfield Foods has submitted IPO documents in the USA, with Citigroup, UBS Group, BNP Paribas, and HSBC serving as underwriters for the IPO.
C+2.36%
23:03
MINISO issues $0.55 billion Convertible Bonds, with a conversion price reaching 102 HKD.
MNSO-8.35%